Filing Details
- Accession Number:
- 0001127602-25-009072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-11 16:28:27
- Reporting Period:
- 2025-03-10
- Filing Date:
- 2025-03-11
- Accepted Time:
- 2025-03-11 16:28:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1891344 | Nancy Valente | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Evp, Chief Development Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 2,565 shares | Avg. Price: $13.60 | Total Value: $34,876.56 |
| Number of Shares After Transactions: | 53,785 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-10 | 2,565 | $13.60 | 53,785 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 6,544 restricted stock units.
- Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,235 shares acquired on June 10, 2024.
Billionaire Hedge Funds
